A Clinical Trial of the Administration of Light Therapy to Prevent Mouth Sores in Children With Cancer
Part of paid clinical trials in Milwaukee, Wisconsin.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT06623305
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Mucositis Oral
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 30 Years
- Healthy Volunteers
- Not accepted
Interventions
- Photobiomodulation for prevention arm — DEVICELight therapy will be administered using the cluster probe on the external cheeks bilaterally and intraorally using the lollipop probe for patients ≥7 years of age. Patients \<7 years of age will not receive intraoral treatment with the lollipop. Instead, they will be asked to open their mouth while the covered cluster probe is held externally to treat their intraoral membranes. Each treatment (both external cheeks and intraoral buccal region) will be administered over 1 min with a Modulation Frequency 2.5Hz, Skin Conduction nS 001, and Beam Power mW 000, for a total treatment time of 3 minutes. Patients will continue to receive light therapy in the home setting through day +8 of their chemotherapy cycle using the Luminance Device.
- Photobiomodulation for exploratory arm — DEVICELight therapy will be administered using the cluster probe on the external cheeks bilaterally and intraorally using the lollipop probe for patients ≥7 years of age. Patients \<7 years of age will not receive intraoral treatment with the lollipop. Instead, they will be asked to open their mouth while the covered cluster probe is held externally to treat their intraoral membranes. Each treatment (both external cheeks and intraoral buccal region) will be administered over 1 min with a Modulation Frequency 2.5Hz, Skin Conduction nS 001, and Beam Power mW 000, for a total treatment time of 3 minutes. Patients will continue to receive light therapy in the home setting through day +8 of their chemotherapy cycle using the Luminance Device.
Study Details
The goal of this clinical trial is to learn if light therapy can prevent mouth sores in children with cancer. The main questions it aims to answer are: Is it reasonable and acceptable to provide light therapy for children with cancer? Does light therapy prevent mouth sores related to medical treatment? Researchers will compare children who do not receive light therapy to children who do receive light therapy during the clinical trial to see if light therapy helps to prevent mucositis. Participants will: * Complete a survey. * Have picture taken of their mouth to look for mouth sores. * Receive light therapy every day while admitted to the hospital on the cancer unit or while admitted to an alternate unit, and continue to receive light therapy in the home setting until they reach 8 days after the start of their chemotherapy cycle.
Key Dates
- First listed
- Oct 2, 2024
- Start date
- Aug 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Aug 31, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: Control ArmProspective data review of patients who did not receive light therapy
- Active Comparator: Prevention ArmProspective data review of patients who did receive light therapy
- Active Comparator: Exploratory ArmProspective review of patients with Trisomy 21 who did receive light therapy
Primary Outcome Measure
Evaluate the feasibility of using PBM in pediatric oncology patients. [ Time Frame: From date of enrollment until date of last PBM treatment, assessed up to 2 years. ]
Central Contacts
- Elissa Shulta, DNP414-266-5407
- Peter Shaw, MD414-955-4086
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Peter Shaw, MD (SUB_INVESTIGATOR) Valerie Lohse, MSN (SUB_INVESTIGATOR) Sarah Joost, MSN (SUB_INVESTIGATOR) Elissa Shulta, DNP (PRINCIPAL_INVESTIGATOR) Meredith Beversdorf, BSN (SUB_INVESTIGATOR) Amberley Kemic, BSN (SUB_INVESTIGATOR) Ashley Hain, BSN (SUB_INVESTIGATOR) Amy Pan, PhD (SUB_INVESTIGATOR) |
Find similar trials in Milwaukee, WI
Related Studies
- Music Therapy for Oral Mucositis Pain in Pediatric PatientsNot Yet Recruiting · University of California, San Francisco · San Francisco, California